Phase 3 Heart Disease Trial, Recruiting (NCT06349941)

Phase 3 Heart Disease Trial, Recruiting NCT06349941 Sponsor: University of Texas Southwestern Medical Center Condition: Heart Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06349941 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Heart Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults aged 18 years or older
People who have been admitted to hospital for acute heart failure at least once in the past 12 months
People who are able to attend medical appointments conducted by video or phone (telemedicine)
People who have access to a smartphone or other device that can run a mobile health app
People who are willing to take part in a heart rehabilitation program carried out at home

Who may not be able to join:

People who have a medical condition that prevents them from safely doing physical exercise or participating in heart rehabilitation
People who are not able to give their own informed consent to take part in the trial
People who do not have access to a smartphone or reliable internet connection
People whose doctors expect them to live less than 6 months
People who are unable to attend telemedicine appointments or be monitored remotely
People who are already enrolled in another heart rehabilitation program

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 15 July 2026

Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06349941

Sponsor: University of Texas Southwestern Medical Center

Phase: Phase 3

Status: Recruiting

Condition: Heart Disease

More information: https://clinicaltrials.gov/study/NCT06349941

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults aged 18 years or older
People who have been admitted to hospital for acute heart failure at least once in the past 12 months
People who are able to attend medical appointments conducted by video or phone (telemedicine)
People who have access to a smartphone or other device that can run a mobile health app
People who are willing to take part in a heart rehabilitation program carried out at home

Who may not be able to join:

People who have a medical condition that prevents them from safely doing physical exercise or participating in heart rehabilitation
People who are not able to give their own informed consent to take part in the trial
People who do not have access to a smartphone or reliable internet connection
People whose doctors expect them to live less than 6 months
People who are unable to attend telemedicine appointments or be monitored remotely
People who are already enrolled in another heart rehabilitation program

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 15 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 3

Sponsor

University of Texas Southwestern Medical Center

Registry

ClinicalTrials.gov

Start date

15 August 2025

Est. completion

1 December 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Composite Hierarchical Endpoint

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov